Abstract
Experiments were carried out to elucidate the role of central catecholamines in regulating catecholamine metabolism in the vas deferens and adrenal gland of the rat. Rats were injected intracerebroventricularly (i.c.v.) with either vehicle or 6-hydroxydopamine (6-OHDA). Groups of animals pretreated with vehicle or 6-OHDA (i.c.v.) were injected intraperitoneally (i.p.) with alpha-methyl-para-tyrosine (AMT), a tyrosine hydroxylase inhibitor. Catecholamine turnover rates were estimated by determining norepinephrine or epinephrine content after administrating AMT.
Central norepinephrine and dopamine contents decreased significantly (p<0.05) after treatment with 6-OHDA and AMT. The norepinephrine content of the vas deferens of rats pretreated with 6-OHDA was markedly reduced (p<0.001) after administration of AMT, whereas that of the vehicle-treated rats remained unchanged. Administration of 6-OHDA had no effect on the norepinephrine or epinephrine content of the adrenal gland.
The present results indicate that central monoaminergic neurons have an inhibitory effect on the adrenergic neurons of the vas deferens. In contrast, this inhibitory regulation does not appear to be exerted on the adrenal glands.
Similar content being viewed by others
Literatur
Sjöstrand, N. O., Acta physiol. scand.56 (1962) 376.
Furness, J. B., and Iwayama, T., J. Anat.113 (1972) 179.
Takamine, J, Am. J. Pharm.73 (1901) 523.
Euler, U. S., and Hamberg, U., Nature163 (1949) 642.
Maas, J. W., Dekirmenjian, H., Garver D., Redmond, D. E. Jr., and Landis, D. H., Eur. J. Pharmac.,23 (1973) 121.
Gauthier, P., and Reader, T. A., Can. J. Physiol. Pharmac.60 (1982) 1464.
Edward, D. J., Ravitch, J., Knopf, S., and Sedlock, M. L., Biochem. Pharmac.34 (1985) 1255.
Nakada, T., and Yamori, Y., Clin. exp. Hypert. A4 (1982) 477.
Benarroch, E. E., Balda, M. S., Finkielmann, S., and Nahmod, V. E., Neuropharmacology22 (1983) 29.
Wagner, J., Vitali, P., Palfreyman, M. G., Zraika, M., and Huot, S., Neurochemistry38 (1982) 1241.
Nakada, T., Furuta, H., and Katayama, T., J. Urol.140 (1988) 1348.
Nakada, T., Sasagawa, I., Furuta, H., and Katayama, T., J. Urol.141 (1989) 998.
Brodie, B. B., Costa, E., Dlabac, A., Neff, N. H., and Smookler, H. H., J. Pharmac. exp. Ther.154 (1966) 493.
Miwa, S., Fujiwara, M., Inoue, M., and Fujiwara, M., J. Neurochem.47 (1986) 63.
Lee, K., Miwa, S., Fujiwara, M., Magaribuchi, T., and Fujiwara, M., J. Pharmac. exp. Ther.240 (1987) 954.
Uretsky, N. J., and Iversen, L. L., J. Neurochem.17 (1970) 269.
Chalmers, J. P., and Reid J. L., Circ. Res.30 (1972) 789.
Kostrzewa, R. M., and Jacobowitz, D. M., Pharmac. Rev.26 (1974) 199.
Sjöstrand, N. O., in: Smooth Muscle: An Assessment of Current Knowledge, chapt. 16 p. 367. Eds. E. Bülbring, A. F. Brading, A. W. Jones and T. Tomita. Edward Arnold Ltd, London 1981.
Westlund, K. N., Bowker, R. M., Ziegler, M. G., and Coulter, J. D., Neurosci. Lett.25 (1981) 243.
Westlund, K. N., Bowker, R. M., Ziegler, M. G., and Coulter, J. D., Brain les.263 (1983) 15.
Siroky, M. B., and Krane, R. J., in: Clinical Neuro-Urology. Little, Brown & Co., Boston, 1979.
Coupland, R. E., in: The Natural History of the Chromaffin Cell. Longmans, London 1965.
Yen, T. J., Kaiwa, T., and Wada, M., Tohoku J. exp. Med.17 (1931) 345.
Luiten, P. G. M., and Ter Horst, G. J., in: Emotions: Neuronal and Chemical Control, p. 369. Ed. Y. Oomura. Japan Sci. Soc. Press, Tokyo 1986.
Weiner, R. I., and Ganong, W. F., Physiol. Rev.58 (1978) 905.
Axelrod, J., Rec. Prog. Horm. Res.21 (1965) 597.
Quik, M., and Sourkes, T. L., J. Neurochem.28 (1977) 137.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamaguchi, T., Nakada, T. Catecholamine metabolism in the vas deferens and the adrenal gland with special reference to the central catecholamine-depleted state. Experientia 48, 667–671 (1992). https://doi.org/10.1007/BF02118315
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02118315